Luis Enjuanes

Madrid, MD 28049, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 95 publications

SARS-CoV-2-derived RNA replicons as safe and effective vaccines.

SARS-CoV-2-derived RNA replicons as safe and effective vaccines.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 24, 2025

Broad-spectrum CRISPR-Cas13d-mediated strategy for combating human coronaviruses.

Broad-spectrum CRISPR-Cas13d-mediated strategy for combating human coronaviruses.

Journal: Molecular therapy. Nucleic acids

Published: September 16, 2025

Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor.

Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor.

Journal: Molecular aspects of medicine

Published: May 13, 2025

SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues.

SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues.

Journal: Journal of virology

Published: April 24, 2025

Interaction between SARS-CoV PBM and Cellular PDZ Domains Leading to Virus Virulence.

Interaction between SARS-CoV PBM and Cellular PDZ Domains Leading to Virus Virulence.

Journal: Viruses

Published: June 19, 2024

Biocompatible Iron Oxide Nanoparticles Display Antiviral Activity Against Two Different Respiratory Viruses in Mice.

Biocompatible Iron Oxide Nanoparticles Display Antiviral Activity Against Two Different Respiratory Viruses in Mice.

Journal: International journal of nanomedicine

Published: April 25, 2024

Correction for Castaño-Rodriguez et al., "Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis".

Correction for Castaño-Rodriguez et al., "Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis".

Journal: mBio

Published: November 10, 2023

Synergism between remdesivir and ribavirin leads to SARS-CoV-2 extinction in cell culture.

Synergism between remdesivir and ribavirin leads to SARS-CoV-2 extinction in cell culture.

Journal: British journal of pharmacology

Published: September 27, 2023

SARS-CoV-2 ORF8 accessory protein is a virulence factor.

SARS-CoV-2 ORF8 accessory protein is a virulence factor.

Journal: mBio

Published: August 25, 2023

SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice.

SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 22, 2023

Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis.

Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis.

Journal: Frontiers in cellular and infection microbiology

Published: July 27, 2023

SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice.

SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice.

Journal: bioRxiv : the preprint server for biology

Published: April 17, 2023

Showing 1-12 of 95

Last Updated: 09/26/2026